NEW YORK, Oct. 20 (GenomeWeb News) - PharmOptima and Shamrock Structures jointly announced today that they will offer each other's capabilities and services for drug discovery and research applications.
Woodbridge, Ill.-based Shamrock provides customers with proteomics services and access to X-ray synchrotron data collection. PharmOptima optimizes assays for high-throughput screening and is conducting research on its own portfolio of therapeutic products.
Terms of the agreement were not disclosed.